COX-2 expression in thymomas and thymic carcinomas: a novel therapeutic target?
Main Authors: | Kern MA, Schirmacher P, Dienemann H, Thomas M, Mechtersheimer G, Schnabel PhA, Rieker RJ |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2007-03-01
|
Series: | Diagnostic Pathology |
Online Access: | http://dx.doi.org/10.1186/1746-1596-2-S1-S3 |
Similar Items
-
Editorial: Novel Treatments for Thymoma and Thymic Carcinoma
by: Arun eRajan, et al.
Published: (2015-11-01) -
Trends in the incidence of thymoma, thymic carcinoma, and thymic neuroendocrine tumor in the United States.
by: Chun-Hsiang Hsu, et al.
Published: (2019-01-01) -
Diagnostic Roles of Immunohistochemistry in Thymic Tumors: Differentiation between Thymic Carcinoma and Thymoma
by: Jae-Han Jeong, et al.
Published: (2020-07-01) -
Thymoma and thymic carcinoma associated with multilocular thymic cyst: a clinicopathologic analysis of 18 cases
by: Xuxia Shen, et al.
Published: (2018-06-01) -
Thymomas and Thymic Carcinomas: A Review on Pathology, Presentation, Staging, Treatment, and Novel Systemic Therapies
by: Keisuke Miyamoto, et al.
Published: (2017-10-01)